Full Event Guide
Download the full event guide to find out more about Cannabinoid Derived Pharmaceuticals Summit Europe and what you can expect across the three days.
Highlights Include how:
- The Hebrew University of Jerusalem are researching CB1 receptor blockers to treat Metabolic Syndrome
- Entourage Phytolab have developed nanotechnology-based formulations to improve bioavailability
- Imperial College London are improving methodology of drug development in pharmaceutical cannabinoids
- Cannabics Pharma are personalising cannabis-based medicine for the treatment of cancer allowing for increased efficacy